fashion -WSS

fashion

author：entertainment 2025-10-02 22:24:44 - browse：123

Hyacinth Empinado/STAT

The body mass index, or BMI, is the formula that’s used most often to diagnose overweight and obesity. But unlike other common diagnoses, there is a certain stigma applied to people with a high body mass index, or BMI, which can affect how they are perceived by peers, providers, and society at large.

Despite the ubiquity of the BMI in medicine, many argue that it is a flawed tool, with a strange history. In recent months, the BMI has become more relevant than ever as the new semaglutide weight loss drugs are poised to change how obesity is understood and treated.

BMI is a simple calculation — a person’s weight in kilograms divided by the square of their height. But how BMI is then translated into a diagnosis is complicated and flawed.

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

Watch this video to learn more about the history of the BMI — how it became so entrenched in medicine and, surprisingly, how its introduction may have set back decades of work on how obesity contributes to disease.

A STAT series is examining new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution.

Previous article： Sports medicine is finally prioritizing gender equality
Next article： With competition flaring, obesity drug hits goal in liver disease study

Wikipedia

hotspot

knowledge

WSS

Patients, doctors press FTC to beef up hospital merger scrutiny

6 phony surgeries that take placebo to the extreme

Obesity drugs seen as possible treatment for liver disease MASH

Akili changes sales model for its ADHD video game treatment

The unintended consequences of overturning Roe v. Wade

Why the quest to eradicate polio has stumbled

entertainment

fashion

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

Wikipedia

DIEP, the 'gold standard' of breast reconstruction, is under threat

Eli Lilly CEO gives to Mike Pence presidential super PAC

How to save PrEP access — and even expand it

Fed up with FDA, ALS advocates consider a take

Medical records are filled with copy

PBM reform efforts get punted in Congress

As demand for Covid shots wanes, Moderna seeks its next success

'A game

United colonoscopy coverage change 'may cost lives,' doctors say

Obesity drugs seen as possible treatment for liver disease MASH

hotspot

With competition flaring, obesity drug hits goal in liver disease study

Midwives could help bridge maternal health disparities in the U.S.

Why the drug industry's warnings on the IRA's impact fall short

Why the quest to eradicate polio has stumbled

Transgender sports debate: Physicians say bans are health issue

He's a Nobel laureate. Critics say he was misleading on Covid

hotspot

hotspot

knowledge

focus